Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis
Hsi-wen Yeh(Institute of Biomedical Sciences, Academia Sinica), Yuh‐Shan Jou(National Health Research Institutes), Chieh-Yu Chang(National Yang Ming Chiao Tung University), Szu-Shuo Lee(National Yang Ming Chiao Tung University), Chun‐Mei Hu(Genomics Research Center, Academia Sinica)
Cited by 56
Related Papers
Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients
|Human Genetics|2002|313
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
|Gastroenterology|2008|253
PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis
|Nature Cell Biology|2018|206
A New Switch for TGFβ in Cancer
|Cancer Research|2019|116